中等症から重症の成人アトピー性皮膚炎患者を対象としたrocatinlimab第III相臨床試験「ROCKET-Horizon」に関するトップラインデータについて PDF：840KB
Topline data on the Phase III clinical trial 'ROCKET-Horizon' of roca-tinlimab targeting adult atopic dermatitis patients from moderate to severe, PDF: 840KB.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.